Debiopharm
Caris Life Sciences Inks CDx Collaboration With Debiopharm
Caris will use its whole-transcriptome sequencing assay and Molecular Intelligence Trials service to identify patients for a phase II clinical trial.
Primerdesign, GenePOC Partner on Near-Patient Flu/RSV MDx
The firms intend to seek CE marking and US Food and Drug Administration clearance for the test.
GenePOC Instrument, Assays Get CE Mark
The firm said that it has completed clinical trials for the Group B Strep assay for the FDA and will start trials for the C. difficile test this month.